CVS Pharmacy has announced that it will limit opioid prescriptions to a seven-day supply for certain conditions, in an effort to combat widespread addiction.
Additionally, when filling prescriptions for opioid pills, CVS pharmacists will be required to talk to patients about the risks of addiction, secure storage of medications in the home and proper disposal.
CVS CEO Larry Merlo would not engage in the debate over the role of drug companies in the drug crisis, telling USA TODAY, "From my perspective, it’s not a blame game at this point. I think as health care stakeholders we all play an important role in being part of the solution."
CVS, one of the largest managers of pharmaceutical benefits in the U.S., plans to roll out these initiatives as of February 1, 2018.
Read the CVS statement